Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients
Authors:
- Michiya KobayashiMKMichiya Kobayashi
- Junichi SakamotoJSJunichi Sakamoto
- Tsutomu NamikawaTNTsutomu Namikawa
- Ken OkamotoKOKen Okamoto
- Takehiro OkabayashiTOTakehiro Okabayashi
- Kengo IchikawaKIKengo Ichikawa
- Keijiro ArakiKAKeijiro Araki
Open Access
- 1 January 2006
- journal article
- case report
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 12 (9) , 1412-1415
Abstract
Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patientsKeywords
This publication has 25 references indexed in Scilit:
- [A case of metastatic gastric cancer responding to weekly administration of paclitaxel as a second-line therapy].2003
- [Effective weekly paclitaxel administration for gastric cancer with malignant ascites--a case report].2002
- Phase II Trial of the Combination of Paclitaxel and 5-Fluorouracil in the Treatment of Advanced Gastric CancerAmerican Journal of Clinical Oncology, 1999
- Paclitaxel-induced apoptosis in human gastric carcinoma cell linesCancer, 1996
- Intraperitoneal taxol1996
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI: Journal of the National Cancer Institute, 1990
- Platinum distribution inintraperitoneal tumors afterintraperitoneal cisplatin treatmentCancer Chemotherapy and Pharmacology, 1990
- Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavityCancer Treatment Reviews, 1986
- Taxol stabilizes microtubules in mouse fibroblast cells.Proceedings of the National Academy of Sciences, 1980